BioSpace News Archive

Biotech Bay

NEUSPERA MEDICAL® ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION

Neuspera® Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced it received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system.

April 18, 2023

·

2 min read

Business

HI-Bio Appoints Industry Veterans Uptal Patel, M.D., as Chief Medical Officer and Sunil Agarwal, M.D., as Board Member

Human Immunology Biosciences (HI-Bio™), today announced the appointment of Uptal Patel , M.D., as Chief Medical Officer.

April 18, 2023

·

4 min read

Genetown

Corbus Pharmaceuticals Hosting Virtual ‘Meet the Expert’ Series: Blocking TGFβ with CRB-601--a New Play for an Old Target

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company, announced that the Company will host the first in the series of virtual ‘Meet the Expert’ events titled Blocking TGFβ with CRB-601—a New Play for an Old Target, on April 25th at 11:00 AM ET.

April 18, 2023

·

3 min read

Biotech Beach

VIALASE ANNOUNCES PUBLICATION OF 24-MONTH SAFETY DATA FROM FIRST IN-HUMAN STUDY OF FEMTOSECOND LASER IMAGE-GUIDED HIGH-PRECISION TRABECULOTOMY (FLigHT)

ViaLase, Inc today announced the online publication of 24-month safety data from the first-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) performed with the ViaLase technology in Ophthalmology® Science, a journal of the American Academy of Ophthalmology.

April 18, 2023

·

3 min read

Genetown

Chiesi Global Rare Diseases Announces U.S. Networkwide Sponsorship of BioInnovation Labs

Chiesi Global Rare Diseases announced a U.S. Networkwide Sponsorship of BioInnovation Labs, the leading developer and operator of life science coworking spaces with 12 active facilities and a growing network in the U.S. and internationally.

April 18, 2023

·

4 min read

Drug Development

OnQuality Pharmaceuticals Presented Preclinical Data for OQL025 and OQL06x, Novel Therapeutics for EGFR inhibitor-induced acneiform rash and diarrhea, at the AACR Annual meeting

OnQuality Pharmaceuticals today announced it presented preclinical data on OQL025 and OQL06x, at the American Association for Cancer Research (AACR) annual meeting. The conference is being held in Orlando, FL, April 14-19, 2023.

April 18, 2023

·

5 min read

Biotech Beach

Tenovi Introduces Cellular FDA-Cleared Remote Peak Flow Meter for Advanced Remote Physiological Monitoring of Asthmatic Patients

Remote patient monitoring (RPM) solutions leader Tenovi announced today that it is launching its cellular-enabled remote Peak Expiratory Flow Meter (PFM).

April 18, 2023

·

2 min read

BioCapital

Incyte to Present at Upcoming Investor Conferences - April 18, 2023

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of May.

April 18, 2023

·

1 min read

Business

Altasciences Completes Clinical Portion of Alzamend Neuro’s Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer’s

Altasciences is proud to support Alzamend Neuro, Inc. (Alzamend) in advancing a novel treatment for dementia related to Alzheimer’s disease (Alzheimer’s).

April 18, 2023

·

3 min read

Genetown

Lumicell™ Direct Visualization System Premarket Approval Application Submitted to U.S. FDA for Intraoperative Breast Cancer Detection and Removal

Lumicell, Inc today announced a Premarket Approval (PMA) application for its Lumicell™ Direct Visualization System (DVS) has been submitted to the U.S. Food and Drug Administration (FDA).

April 18, 2023

·

4 min read